Human endo-lysosomes possess a class of proteins called TPC channels on their membrane, which are essential for proper cell functioning. This protein family can be functionally studied by expressing them in plant vacuoles. Inhibition of hTPC activity by naringenin, one of the main flavonoids present in the human diet, has the potential to be beneficial in severe human diseases such as solid tumor development, melanoma, and viral infections. We attempted to identify the molecular basis of the interaction between hTPC2 and naringenin, using ensemble docking on molecular dynamics (MD) trajectories, but the specific binding site remains elusive, posing a challenge that could potentially be addressed in the future by increased computational power in MD and the combined use of microscopy techniques such as cryo-EM.

Download full-text PDF

Source
http://dx.doi.org/10.1515/bmc-2022-0036DOI Listing

Publication Analysis

Top Keywords

commentary inhibition
4
human
4
inhibition human
4
human tpc2
4
tpc2 channel
4
channel natural
4
natural flavonoid
4
flavonoid naringenin
4
naringenin methods
4
methods experiments
4

Similar Publications

Spotlight on YAP: Unlocking New Insights to Overcome the Barriers to Heart Regeneration.

Circulation

January 2025

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA (N.V., R.T.L.).

This editorial refers to “Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration” by Liu . and “YAP Overcomes Mechanical Barriers to Induce Mitotic Rounding and Adult Cardiomyocyte Division” by Morikawa

View Article and Find Full Text PDF

Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies.

World J Diabetes

December 2024

Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, Taichung City 404333, Taiwan.

This article provides commentary on the article by Zhang . In this original research, Zhang investigated the therapeutic potential of teneligliptin for diabetic cardiomyopathy (DCM), which was mediated by targeting the NOD-like receptor protein 3 (NLRP3) inflammasome. Through the use of both and models, the study demonstrated that teneligliptin alleviates cardiac hypertrophy, reduces myocardial injury, and mitigates the inflammatory responses associated with DCM.

View Article and Find Full Text PDF

New insights into FGF21 alleviates diabetic cardiomyopathy by suppressing ferroptosis: a commentary.

Cardiovasc Diabetol

November 2024

Department of Cardiology, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Diabetic cardiomyopathy (DCM) is a severe cardiovascular complication of diabetes characterized by myocardial hypertrophy, fibrosis, and impaired cardiac function. Fibroblast growth factor 21 (FGF21) has emerged as a promising therapeutic target due to its antifibrotic, antioxidant, and anti-inflammatory properties. Our commentary summarizes and affirms the recent study by Wang et al.

View Article and Find Full Text PDF

Checkpoint inhibition in macroglobulinaemia.

Br J Haematol

December 2024

Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

Waldenström macroglobulinaemia (WM) is a unique, cluster of differentiation (CD) 20+ B-cell malignancy, with a characteristic immunoglobulin M-secreting lymphoplasmacytic bone marrow infiltrate that is bolstered by a highly supportive microenvironment, including upregulated programmed death 1 expression. However, the impact of checkpoint inhibition in WM is unclear. Commentary on: Kothari et al.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!